Cargando…
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
BACKGROUND: Portal hypertension and cardiac alterations previously described as "cirrhotic cardiomyopathy" are known complications of end stage liver disease (ELD). Cardiac failure contributes to morbidity and mortality, particularly after liver transplantation and transjugular intrahepati...
Autores principales: | Lossnitzer, Dirk, Steen, Henning, Zahn, Alexandra, Lehrke, Stephanie, Weiss, Celine, Weiss, Karl Heinz, Giannitsis, Evangelos, Stremmel, Wolfgang, Sauer, Peter, Katus, Hugo A, Gotthardt, Daniel N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924326/ https://www.ncbi.nlm.nih.gov/pubmed/20704762 http://dx.doi.org/10.1186/1532-429X-12-47 |
Ejemplares similares
-
Contrast enhanced delayed myocardial enhancement in patients with end stage liver cirrhosis – further evidence for cirrhotic cardiomyopathy
por: Lossnitzer, Dirk, et al.
Publicado: (2009) -
GEISIR: gadolinium exposure induced systemic inflammatory response in dialysis patients
por: Steen, Henning, et al.
Publicado: (2009) -
Hepatic and Renal Failure after Anterior Myocardial Infarction Induced Apical Ventricular Septal Defect
por: Lossnitzer, Dirk, et al.
Publicado: (2010) -
Safety and feasibility of high dose stress dobutamine mri very early after acute myocardial infarction
por: Mamone, Michael, et al.
Publicado: (2011) -
Assessment of right and left ventricular trabeculation in a reference collective: gender and age dependency of myocardial trabeculation
por: Burger, Astrid, et al.
Publicado: (2011)